Opioid Drugs: Global Markets to 2023

Report Code: PHM207A

Publish Date: Dec 2018

Publisher: BCC Publishing

Category: Pharmaceuticals

Customize This Report

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for opioid drugs should reach $29.8 billion by 2023 from $26.4 billion in 2018 at a compound annual growth rate (CAGR) of 2.5% for the period of 2018-2023.

Report Includes

  • 20 data tables and 38 additional tables
  • An overview of the global market for opioid drugs
  • Analyses of global market trends, with data from 2017 to 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Discussion of types, mode of action and receptor target of opioids drugs i.e. Mu receptor, Delta receptor and Kappa receptor
  • Details of technological advancement for new opioid formulation to reduce the risk of drug abuse
  • Case study of opioid addiction, opioid abuse and overdose and significant events addressing opioid misuse and abuse
  • Information on stringent regulatory policies and government guidelines to impede the adoption rate of the opioid drugs
  • Insights of new safety measures announced for immediate release (IR) opioids and CDC guidelines on prescribing opioids for chronic pain
  • Company profiles of the major players of the market, including Acura Pharmaceuticals Inc., Cipher Pharmaceutical Inc., Daiichi Sankyo Inc., Johnson & Johnson, Lupin Ltd., Pfizer Inc., Sun Pharmaceuticals and Teva Pharmaceutical Industries Ltd.

Report Scope

The current report offers a detailed picture of the prescription opioid drug market. Prescription opioids are included in the scope of study; illegal opioids such as heroin, which are sold in illegal market for illicit usage, are not included. The market estimation includes all branded and generic opioid drugs indicated for different therapeutic application such as pain management and opioid use disorders.

This report highlights the current and future market potential of opioid drugs along with detailed analyses of the competitive environment, regulatory scenario, pipeline analysis, technological advancement and market dynamics.

The report details market shares of opioid drugs based on product and geography. Based on product, the market is segmented into buprenorphine, fentanyl, hydrocodone, morphine, oxycodone, tramadol and others. Each product segment includes detailed analyses covering an overview of drug, mechanism of action and market insights on each drug.

By geography, the market has been segmented into North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. Detailed analyses of major countries such as the U.S., Germany, the U.K. France, Japan, China and India are covered in regional segments. For market estimates, data has been provided for the year 2017 and the base year of 2018 and forecast for 2023. Estimated values used are based on drug manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Latest reports include:
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Opioid Drugs: Global Markets to 2023147Free
Chapter- 1: Introduction5Free
Chapter- 2: Summary and Highlights2Free
Chapter- 3: Market and Technology Background13Free
Chapter- 4: Market Dynamics 12Free
Chapter- 5: Market Breakdown by Product29Free
Chapter- 6: Market Breakdown by Region32Free
Chapter- 7: Regulatory Environment9Free
Chapter- 8: Pipeline Analysis3Free
Chapter- 9: Competitive Landscape6Free
Chapter- 10: Company Profiles34Free
Chapter- 11: Appendix: Acronyms2Free

Related Reports

Substance Use Disorder Treatment: Global Markets to 2030

Published - Jun 2026 | Publisher - BCC Publishing | Code - PHM035D

The global substance use disorder (SUD) treatment market was valued at $11.6 billion in 2025, and it is expected to reach $14.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 4.6% from 2025 to 2030.

Cannabis Market: Products, Technologies, and Applications

Published - Jan 2026 | Publisher - BCC Publishing | Code - PHM217B

The global market for cannabis was valued at $45.6 billion in 2025 and is projected to reach $79.3 billion by the end of 2030, at a compound annual growth rate (CAGR) of 11.7% during the forecast period of 2025 to 2030.

2023 Pharmaceuticals Research Review

Published - Dec 2024 | Publisher - Various Analysts | Code - PHM099H

This Pharmaceutical Research Review provides a sampling of the type of quantitative market information, analysis and guidance that has been aiding business decision making since the inception of BCC Research in 1971.

Global Markets for Generic Drugs

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM009K

The global market for generic drugs is expected to grow from $435.3 billion in 2023 and projected to reach $655.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 8.5% from 2023 to 2028.

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 58

  • Summary Table: Global Opioid Drug Market, by Product, Through 2023
  • Table 1: Analgesic Effects of Drugs at Different Opioid Receptors
  • Table 2: Timeline of Selected FDA Activities and Events Related to Opioid Misuse and Abuse, 1911-2018
  • Table 3: FDA Approved Opioids with ADF Labeling
  • Table 4: Opioid Lawsuit Settlements, 2015-2027
  • Table 5: Global Opioid Drug Market, by Product, Through 2023
  • Table 6: Global Buprenorphine Drug Market, by Region, Through 2023
  • Table 7: Global Fentanyl Drug Market, by Region, Through 2023
  • Table 8: Global Hydrocodone Drug Market, by Region, Through 2023
  • Table 9: Global Morphine Drug Market, by Region, Through 2023
  • Table 10: Global Oxycodone Drug Market, by Region, Through 2023
Sample Report

Recent Reports

Global Topical Drug Delivery Market

Published - Aug 2026 | Publisher - BCC Publishing | Code - PHM292A

The global topical drug delivery market was valued at $222.9 billion in 2025 and is estimated to increase from $239 billion in 2026 to reach $362.3 billion by the end of 2031, at a compound annual growth rate (CAGR) of 8.7% from 2026 to 2031.

Blood Cancer Therapeutics: Global Markets to 2030

Published - Jul 2026 | Publisher - BCC Publishing | Code - PHM210B

The global market for blood cancer therapeutics was valued at $77.1 billion in 2025 and is projected to reach $125.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 10.2% from 2025 to 2030.

Clinical Nutrition: Global Markets to 2031

Published - Jun 2026 | Publisher - BCC Publishing | Code - PHM198C

The global market for clinical nutrition is expected to grow from $79.5 billion in 2026 and is projected to reach $104.7 billion by the end of 2031, at a compound annual growth rate (CAGR) of 5.6% during the forecast period of 2026 to 2031.

Substance Use Disorder Treatment: Global Markets to 2030

Published - Jun 2026 | Publisher - BCC Publishing | Code - PHM035D

The global substance use disorder (SUD) treatment market was valued at $11.6 billion in 2025, and it is expected to reach $14.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 4.6% from 2025 to 2030.

In Vitro Toxicity Testing: Technologies and Global Markets

Published - May 2026 | Publisher - BCC Publishing | Code - PHM017H

The global in vitro toxicity testing market was valued at $17.4 billion in 2025 and is projected to reach $28 billion by the end of 2030, at a compound annual growth rate of 10% from 2025 to 2030.

Top Trending Reports

State of the Life Sciences Industry - 2026 Second Quarter Review

Published - Jul 2026 | Publisher - BCC Publishing | Code - HLC314D

Discover BCC Research’s Q2 2026 life sciences industry review, highlighting market trends, innovation, sector performance, and growth opportunities.

Cardiovascular Devices: Global Markets to 2030

Published - Jul 2026 | Publisher - BCC Publishing | Code - HLC210B

The global market for cardiovascular devices is expected to grow from $72.4 billion in 2025 and is projected to reach $101.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.0% during the forecast period of 2025 to 2030.

Global Veterinary Medical Devices Market

Published - Jul 2026 | Publisher - BCC Publishing | Code - MDS113A

This report provides an in-depth analysis of the global veterinary medical devices market by device type, animal type, and region. It examines key market trends, technologies, competitive dynamics, and challenges influencing the industry. Regional analysis covers North America, Europe, Asia-Pacific, the Middle East & Africa, and South America, with a focus on major countries within these regions. The study also includes profiles of leading companies, highlighting financials, product portfolios, and recent developments, along with market forecasts through 2030.

Global HLA Typing for Transplant Market

Published - Jul 2026 | Publisher - BCC Publishing | Code - BIO277A

This report analyzes the global HLA typing for transplant market, covering market size, growth trends, industry dynamics, emerging technologies, and competitive developments. The market is segmented by product and service type, technology, application, end user, and region, with coverage across North America, Europe, Asia-Pacific, and the Rest of the World. The study includes insights into key applications such as solid organ and hematopoietic stem cell transplants, along with profiles of leading companies and forecasts through 2030.

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Jun 2026 | Publisher - BCC Publishing | Code - BIO099G

The global market for single-use technologies (SUTs) for biopharmaceuticals was valued at $8.3 billion in 2025 and, is estimated to reach $9.2 billion by 2026 and $16.3 billion by 2031, at a compound annual growth rate (CAGR) of 12.2% from 2026 through 2031.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Opioid Drugs: Global Markets to 2023
Customize Report
AI Sentiment